Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invitae has served over five million patients with medical-grade genetic tests covering oncology, cardiology, rare diseases, pediatrics, and reproductive health. The company’s clinical results have enabled earlier diagnoses and more personalized care plans but it faced financial challenges leading to bankruptcy in early 2024. Its technology remains widely used through partnerships with biopharma companies to support clinical trials and research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invitae.